Patent Yard Sign in
Expired Canadian patentCanada

Fibrin binding domain polypeptides and uses and methods of producing same

CA 2083271 C · Owner: Guy, Rachel · Inventors: Panet, Amos; Hartman, Jacob; Levanon, Avigdor

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention provides an imaging agent which comprises a polypeptide labeled with an imageable marker, such polypeptide having an amino acid sequence substantially present in the fibrin binding domain of naturally-occuring human fibronectin and being capable of binding to fibrin. The invention further provides a method wherein the imaging agent is used for imaging a fibrin-containing substance, i.e. a thrombus or atherosclerotic plaque. Further provided are plasmids for expression of polypeptides having an amino acid sequence substantially present in the fibrin binding domain of naturally-occuring human fibronectin and being capable of binding to fibrin hosts containing these …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 21, 1991 and granted April 9, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 21, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 21, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 21, 1991
GrantedApril 9, 2002
Term endedMay 21, 2011
Patent numberCA 2083271 C
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedMay 21, 1991Patent grantedApril 9, 2002Term endedMay 21, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.